Case Reports
Use of Isoquercetin in the Treatment of Prurigo Nodularis
November 2017 | Volume 16 | Issue 11 | Case Reports | 1156 | Copyright © November 2017
Atopic dermatitis and prurigo nodularis result from complex interactions between the skin, the immune system, and the external environment. The pruritus associated with these conditions greatly imp...
Read MoreGranuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma
October 2017 | Volume 16 | Issue 10 | Case Reports | 1050 | Copyright © October 2017
Numerous cutaneous manifestations have been associated with use of BRAF inhibitors, including two previously reported cases of granuloma annulare (GA) eruptions associated with vemurafenib therapy. Bo...
Read MoreDevelopment of Halo Nevi in a Lung Cancer Patient: A Novel Immune-Related Cutaneous Event from Atezolizumab
October 2017 | Volume 16 | Issue 10 | Case Reports | 1047 | Copyright © October 2017
Immunotherapy-induced vitiligo is an immune-related adverse event (irAE) observed in metastatic melanoma patients treated with immune checkpoint inhibitors that target the cytotoxic T-lymphocyte-assoc...
Read MoreTrimethoprim-Sulfamethoxazole-Induced Drug Eruption With Eosinophilia and Systemic Symptoms (DRESS)
October 2017 | Volume 16 | Issue 10 | Case Reports | 1043 | Copyright © October 2017
Drug rash with eosinophilia and systemic symptoms (DRESS) is a severe and potentially life threatening adverse drug reaction. To help identify DRESS, several criteria have been established; however, t...
Read MoreAutoimmune Progesterone Dermatitis: A Diagnosis to Consider in a Patient With Cyclical Cutaneous Eruptions
October 2017 | Volume 16 | Issue 10 | Case Reports | 1040 | Copyright © October 2017
Autoimmune progesterone dermatitis (APD) is a cyclical cutaneous reaction to progesterone, with symptoms that typically begin 3-10 days before the onset of menstrual flow and end 1-2 days into menses....
Read MoreSerpiginous Purpuric Eruption of the Leg
October 2017 | Volume 16 | Issue 10 | Case Reports | 1036 | Copyright © October 2017
A previously healthy 68-year-old male presented with a rash on his right lower leg. The lesions had spread along the leg since onset 9 days prior, and the patient reported localized soreness and pruri...
Read MoreLifting the Lower Face With an Absorbable Polydioxanone (PDO) Thread
September 2017 | Volume 16 | Issue 9 | Case Reports | 932 | Copyright © September 2017
Traditional rejuvenation techniques include chemical peels, rhytidectomy of the skin, laser resurfacing, injection of dermal fillers and neurotoxins, and invasive surgical procedures. Patients with br...
Read MoreMild to Moderate Dysphagia Following Very Low-dose Abobotulinumtoxin A for Platysmal Bands
September 2017 | Volume 16 | Issue 9 | Case Reports | 929 | Copyright © September 2017
Onabotulinumtoxin A (Botox) can be a safe and successful off-label treatment of vertical platysma bands of various severities. Due to risk of the botulinum toxin diffusing to the underlying anatomic s...
Read MoreSuccessful Treatment of Keloid With Fractionated Carbon Dioxide (CO2) Laser and Laser-Assisted Drug Delivery of Triamcinolone Acetonide Ointment in an African-American Man
September 2017 | Volume 16 | Issue 9 | Case Reports | 925 | Copyright © September 2017
Keloids are fibrous growths that occur as a result of abnormal response to dermal injury. Keloids are cosmetically disfiguring and may impair function, often resulting in decreased patient quality-of-...
Read MoreTemporal Association of Herpes Zoster Eruption Post-Aminolevulinic Acid Hydrochloride Photodynamic Therapy for Actinic Keratoses
August 2017 | Volume 16 | Issue 8 | Case Reports | 817 | Copyright © August 2017
Herpes zoster is a common and painful disease caused by the reactivation of the varicella-zoster virus with a higher incidence and severity associated with increasing age as well as compromised imm...
Read MoreTwenty-Nail Transverse Melanonychia Induced by Hydroxyurea: Case Report and Review of the Literature
August 2017 | Volume 16 | Issue 8 | Case Reports | 814 | Copyright © August 2017
Twenty-nail transverse melanonychia from hydroxyurea is a rare phenomenon, only reported four times previously. Here we describe a 51-year-old female who presented with 20-nail transverse melanonyc...
Read MoreSubmammary Granular Parakeratosis Treated With Mastopexy
August 2017 | Volume 16 | Issue 8 | Case Reports | 810 | Copyright © August 2017
Granular parakeratosis, originally named axillary granular parakeratosis, is an uncommon disease with an unclear etiology. It is thought to result from defective processing of profillagrin to filla...
Read MoreSchnitzler Syndrome With Delirium and Vertigo: The Utility of Neurologic Manifestations in Diagnosis
June 2017 | Volume 16 | Issue 6 | Case Reports | 625 | Copyright © June 2017
Schnitzler syndrome (SS) is an autoinflammatory dermatosis that often goes undiagnosed for 5-6 years. Patients typically carry a diagnosis of urticaria; however, their cutaneous symptoms fail to re...
Read MoreEruptive Milia Within a Tattoo: A Case Report and Review of the Literature
June 2017 | Volume 16 | Issue 6 | Case Reports | 621 | Copyright © June 2017
Of the many tattoo reactions the most common are allergic, granulomatous, lichenoid, photosensitive, pseudolymphomatous, and infectious. Eruptive milia are a rare complication with only three prior...
Read MoreEruptive Melanocytic Acral Nevi in the Setting of 6-mercaptopurine Therapy
May 2017 | Volume 16 | Issue 5 | Case Reports | 516 | Copyright © May 2017
Eruptive melanocytic nevi (EMN) are a rare clinical finding characterized by sudden-onset nevi that often present in a grouped distribution. They have been associated with chemotherapy, immunosuppr...
Read MoreCase Report of Multiple Keratoacanthomas and Squamous Cell Carcinomas in a Patient Receiving Pembrolizumab
May 2017 | Volume 16 | Issue 5 | Case Reports | 513 | Copyright © May 2017
PD-1 is expressed on antigen-stimulated T cells and induces a downstream signaling pathway that works by negative feedback to inhibit T cell proliferation, cytokine release, and cytotoxicity. PD-1 ...
Read MoreAggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor Ruxolitinib
May 2017 | Volume 16 | Issue 5 | Case Reports | 508 | Copyright © May 2017
The Food and Drug Administration approved Ruxolitinib in 2011 for the treatment of primary myelofibrosis. Five-year safety data showed a higher incidence of skin cancer in patients treated with Rux...
Read MoreA Difference in Cutaneous Pigmentary Response to LED Versus Halogen Incandescent Visible Light: A Case Report from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose
April 2017 | Volume 16 | Issue 4 | Case Reports | 388 | Copyright © April 2017
BACKGROUND: While most of the attention regarding skin pigmentation has focused on the effects on ultraviolet radiation, the cutaneous effects of visible light (400 to 700nm) are rarely reported. I...
Read MoreThe Transposition Flap for the Reconstruction of Lower Cutaneous Lip Defects
April 2017 | Volume 16 | Issue 4 | Case Reports | 385 | Copyright © April 2017
The lower cutaneous lip is a highly visible and functionally sensitive unit, and numerous factors must be considered when deciding on the optimal repair for defects in this area. The transposition ...
Read MoreSingle-Staged Tunneled Cheek Interpolation Flap With Cartilage Batten Graft for Repair of Nasal Ala Defect
March 2017 | Volume 16 | Issue 3 | Case Reports | 288 | Copyright © March 2017
Surgical defects located within 5 mm of the nasal alar margin are at risk for alar elevation or collapse of the external nasal valve during wound healing. To reduce the chance of such complications...
Read More